LB vs REGN
LandBridge Company LLC (LB) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
LandBridge Company LLC (LB) is a oil & gas equipment & services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LB revenue for 2024-12-31 was $110.0M. Net income was $5.4M. Revenue was up 50.9% from 2023-12-31 to 2024-12-31. LB currently screens at market cap $5.54B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LB currently screens at market cap $5.54B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LB and REGN stock pages for the full models.
Not investment advice.